Selective Chelators for Metals on Cells and Cancer Chemotherapy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 5562
Special Issue Editor
Interests: organic chemistry; tetrazoles, thiazoles and thiadiazoles; nitrogen ligands; organocatalysis; metal catalysis; selective chelators for metals on biological medium; leads for cancer chemotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer research continues to be one of the leading banners in medicine and the pharmaceutical sciences. Since this is a topic of great interest to society, the fields of knowledge that act directly in the fight against this disease are numerous and are transversal to different central sciences, such as chemistry, physics or biology. In this context, there are several types of treatments applied for cancer eradication, with chemotherapy procedures leading the way. Besides, the designation of cancer chemotherapy by yourself is quite broad, comprising a large number of medicines and medical practices.
One of the approaches used to combat cancer cell proliferation is based on the application of molecules with chelating / ligand properties, selective for different metals in cell media. In this context, the present special Issue aims to combine a collection of original and review articles comprising basic science, preclinical and clinical discoveries that embrace metal-chelating compounds for cancer chemotherapy.
Dr. Luís M. T. Frija
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinorganic chemistry
- cancer chemotherapy
- metal chelation
- ligands
- reactive oxigen species
Related Special Issues
- Metallodrugs in Pharmaceuticals
- Metal-Based Drugs in Pharmaceuticals (1 article)
- Metal-Based Drugs: Updates and Perspectives in Pharmaceuticals (14 articles)
